Search research articles
Contact Us
Filters
Showing results (1-10 of 175) with videos related to
Page
of 18
Sort By:
Archives of Pathology & Laboratory Medicine
|
August 1, 1986
Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease
N Rifai
Cardiovascular Toxicology
|
September 6, 2002
C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention
N Rifai
Clinical Biochemistry
|
February 13, 2001
High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy
H Yu, N Rifai
Current Opinion in Lipidology
|
October 1, 1994
Clinical chemistry and coagulation
I Jialal, N Rifai
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 23, 2000
Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method
M Nauck, N Rifai
Clinical Chemistry
|
September 1, 1989
Immunoturbidimetry of beta 2-microglobulin in serum
N Rifai, A Morales
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 16, 1987
A simple immunotechnique for the determination of serum concentration of apolipoprotein E
N Rifai, L M Silverman
Clinical Chemistry
|
June 1, 1986
Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum
N Rifai, M E King
Annals of Clinical and Laboratory Science
|
September 1, 1987
Further evidence for the heterogeneity of high density lipoprotein isolates: HDL2:HDL3 cholesterol ratios and the presence of apolipoprotein B
N Rifai, M E King
Clinical Chemistry
|
January 10, 2001
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
N Rifai, P M Ridker
Page
of 18
Search research articles
Search
Showing results (1-10 of 175) with videos related to
Sort By:
Page
of 18
Archives of Pathology & Laboratory Medicine
|
August 1, 1986
Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease
N Rifai
Cardiovascular Toxicology
|
September 6, 2002
C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention
N Rifai
Clinical Biochemistry
|
February 13, 2001
High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy
H Yu, N Rifai
Current Opinion in Lipidology
|
October 1, 1994
Clinical chemistry and coagulation
I Jialal, N Rifai
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 23, 2000
Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method
M Nauck, N Rifai
Clinical Chemistry
|
September 1, 1989
Immunoturbidimetry of beta 2-microglobulin in serum
N Rifai, A Morales
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 16, 1987
A simple immunotechnique for the determination of serum concentration of apolipoprotein E
N Rifai, L M Silverman
Clinical Chemistry
|
June 1, 1986
Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum
N Rifai, M E King
Annals of Clinical and Laboratory Science
|
September 1, 1987
Further evidence for the heterogeneity of high density lipoprotein isolates: HDL2:HDL3 cholesterol ratios and the presence of apolipoprotein B
N Rifai, M E King
Clinical Chemistry
|
January 10, 2001
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
N Rifai, P M Ridker
Page
of 18